tenk.fyi

INTENSITY THERAPEUTICS, INC.

INTSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$16.3M

54.4% YoY

EPS

$-1.17

15.2% YoY

Cash

$2.6M

69.7% YoY

FY 2024 · As of 2024-12-31